Sirt7 is high expressed in breast cancer, which is an indicator of poor prognosis, and the expression of Sirt7 is positively correlated with the expression of IRF5 and PD1, which increases M1 macrophages, and depletes T cells in the immune environment of breast cancer (Huo et al., 2020). Here, SIRT7 is linked to breast carcinoma.